chr8-144464856-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000306145.10(TMEM276):āc.46C>Gā(p.Leu16Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000388 in 1,612,750 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000306145.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM276-ZFTRAF1 | NM_001408008.1 | c.46C>G | p.Leu16Val | missense_variant | 2/6 | NP_001394937.1 | ||
TMEM276-ZFTRAF1 | NM_001408009.1 | c.46C>G | p.Leu16Val | missense_variant | 2/6 | NP_001394938.1 | ||
TMEM276-ZFTRAF1 | NM_001408010.1 | c.46C>G | p.Leu16Val | missense_variant | 2/6 | NP_001394939.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000291316 | ENST00000438911.6 | c.46C>G | p.Leu16Val | missense_variant | 1/5 | 2 | ENSP00000387426.2 | |||
TMEM276 | ENST00000306145.10 | c.46C>G | p.Leu16Val | missense_variant | 2/3 | 1 | ENSP00000304826.5 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152264Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000221 AC: 55AN: 249402Hom.: 0 AF XY: 0.000207 AC XY: 28AN XY: 135410
GnomAD4 exome AF: 0.000405 AC: 591AN: 1460486Hom.: 1 Cov.: 39 AF XY: 0.000399 AC XY: 290AN XY: 726576
GnomAD4 genome AF: 0.000230 AC: 35AN: 152264Hom.: 0 Cov.: 34 AF XY: 0.000175 AC XY: 13AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.46C>G (p.L16V) alteration is located in exon 1 (coding exon 1) of the CYHR1 gene. This alteration results from a C to G substitution at nucleotide position 46, causing the leucine (L) at amino acid position 16 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at